RX MEDICAL SERVICES CORP
NT 10-Q, 2000-08-15
MEDICAL LABORATORIES
Previous: PAMET SYSTEMS INC, 10QSB, EX-27, 2000-08-15
Next: TEMPLETON CAPITAL ACCUMULATOR FUND INC, DEFS14A, 2000-08-15



<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q
             [ ] Form N-SAR

                         For Period Ended: June 30, 2000

                         [ ] Transition Report on Form 10-K
                         [ ] Transition Report on Form 20-F
                         [ ] Transition Report on Form 11-K
                         [ ] Transition Report on Form 10-Q
                         [ ] Transition Report on Form N-SAR

                         For the Transition Period Ended:____________________


  READ ATTACHED INSTRUCTION SHEET BEFORE PREPARING FORM. PLEASE PRINT OR TYPE.

    Nothing in this form shall be construed to imply that the commission has
                   verified any information contained herein.

If the notification relates to a portion of the filing checked above, indentify
the item(s) to which the notification relates:


--------------------------------------------------------------------------------
                         PART I - REGISTRANT INFORMATION
--------------------------------------------------------------------------------

Rx Medical Services Corp.
-------------------------------------------------------------
Full name of registrant


ARM Financial Corp.
-------------------------------------------------------------
Former name if applicable


888 East Las Olas Boulevard, Suite 210
-------------------------------------------------------------
Address of principal executive office (Street and Number)


Fort Lauderdale, Florida  33301
-------------------------------------------------------------
City, state and zip code

--------------------------------------------------------------------------------
                       PART II - RULE 12-b-25(b) AND (c)
--------------------------------------------------------------------------------

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check box if appropriate)

[X]      (a)      The reasons described in reasonable detail in Part III of this
                  form could not be eliminated without reasonable effort or
                  expense;

[ ]      (b)      The subject annual report semi-annual report, transition
                  report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion
                  thereof will be filed on or before the fifteenth calendar day
                  following the prescribed due date; or the subject quarterly
                  report or transition report on Form 10-Q, or portion thereof
                  will be filed on or before the fifth calendar day following
                  the prescribed due date; and

[ ]      (c)      The accountant's statement or other exhibit required by Rule
                  12b-25(c) has been attached if applicable.



<PAGE>   2

--------------------------------------------------------------------------------
                              PART III - NARRATIVE
--------------------------------------------------------------------------------

State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof could not be filed within the
prescribed period. (Attached extra sheets if needed.)

         The audit of the financial statements of the registrant for the years
         ended December 31, 1998 and 1999 have not yet been completed. Once said
         audits are completed and the registrant's annual report on Form 10-K
         for the years ended December 31, 1998 and 1999 are filed, the
         registrant will be in a position to file unaudited financial statements
         for the quarter ended June 30, 2000. The registrant anticipates that is
         Form 10-Q for the second quarter ended June 30, 2000 will be filed on
         or about June 30, 2001.

--------------------------------------------------------------------------------
                           PART IV - OTHER INFORMATION
--------------------------------------------------------------------------------

(1)      Name and telephone number of person to contact in regard to this
         notification


             Dennis A. Dolnick           954             462-1711 (Ext #14)
         ------------------------  ----------------  --------------------------
                   (Name)            (Area Code)         (Telephone Number)

(2)      Have all other periodic reports required under section 13 or 15(d) of
         the Securities Exchange Act of 1934 or section 30 of the Investment
         Company Act of 1940 during the preceding 12 months or for such shorter
         period that the registrant was required to file such report (s) been
         filed? If the answer is no, identify report(s).

                                                       [ ]  Yes        [X]  No

         The annual report on Form 10-K for the year ended December 31, 1998.
         The quarterly report on Form 10-Q for the quarter ended March 31, 1999.
         The quarterly report on Form 10-Q for the quarter ended June 30, 1999.
         The quarterly report on Form 10-Q for the quarter ended September 30,
         1999.
         The annual report on Form 10-K for the year ended December 31, 1999.
         The quarterly report on Form 10-Q for the quarter ended March 31, 2000.

(3)      Is it anticipated that any significant change in results of operations
         from the corresponding period for the last fiscal year will be
         reflected by the earnings statements to be included in the subject
         report or portion thereof?

                                                       [ ]  Yes        [X]  No

         If so: attach an explanation of the anticipated change, both
         narratively and quantitatively, and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.

                            Rx MEDICAL SERVICES CORP.
--------------------------------------------------------------------------------
                  (Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date:  August 15, 2000                        By: /s/ Michael L. Goldberg
                                                  ---------------------------
                                                  Michael L. Goldberg
                                                  Chief Executive Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

--------------------------------------------------------------------------------
                                    ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
--------------------------------------------------------------------------------



                                       2
<PAGE>   3

--------------------------------------------------------------------------------
                              GENERAL INSTRUCTIONS
--------------------------------------------------------------------------------


1.       This form is required by Rule 12b-25 of the General Rules and
         Regulations under the Securities Exchange Act of 1934.

2.       One signed original and four conformed copies of this form and
         amendments thereto must be completed and filed with the Securities and
         Exchange Commission, Washington, DC 20549, in accordance with Rule o-3
         of the General Rules and Regulations of the Act. The information
         contained in or filed with the form will be made a matter of public
         record in the Commission files.

3.       A manually signed copy of the form and amendments thereto shall be
         filed with each national securities exchange on which any class of
         securities of the registrant is registered.

4.       Amendments to the notification must be filed on Form 12b-25 but need
         not restate information that has been correctly furnished. The form
         shall be clearly identified as an amendment notification.

5.       ELECTRONIC FILERS. This form shall not be used by electronic filers
         unable to timely file a report solely due to electronic difficulties.
         Filers unable to submit a report within the time period prescribed due
         to difficulties in electronic filing should comply with either Rule 201
         or Rule 202 of Regulation S-T or apply for an adjustment in filing date
         pursuant to Rule 13)b) of Regulation S-T.





                                       3


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission